annual CFI:
-$33.00K-$33.00K(-100.00%)Summary
- As of today (September 15, 2025), AKBA annual cash flow from investing activities is -$33.00 thousand, with the most recent change of -$33.00 thousand (-100.00%) on December 31, 2024.
- During the last 3 years, AKBA annual CFI has fallen by -$39.97 million (-100.08%).
- AKBA annual CFI is now -100.02% below its all-time high of $211.18 million, reached on December 31, 2019.
Performance
AKBA Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
-$126.00K-$280.00K(-181.82%)Summary
- As of today (September 15, 2025), AKBA quarterly cash flow from investing activities is -$126.00 thousand, with the most recent change of -$280.00 thousand (-181.82%) on June 1, 2025.
- Over the past year, AKBA quarterly CFI has dropped by -$97.00 thousand (-334.48%).
- AKBA quarterly CFI is now -100.11% below its all-time high of $110.47 million, reached on March 31, 2019.
Performance
AKBA quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$24.00K-$97.00K(-80.17%)Summary
- As of today (September 15, 2025), AKBA TTM cash flow from investing activities is $24.00 thousand, with the most recent change of -$97.00 thousand (-80.17%) on June 1, 2025.
- Over the past year, AKBA TTM CFI has increased by +$53.00 thousand (+182.76%).
- AKBA TTM CFI is now -99.99% below its all-time high of $211.18 million, reached on December 31, 2019.
Performance
AKBA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
AKBA Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | -334.5% | +182.8% |
| 3 y3 years | -100.1% | -100.0% | +121.0% |
| 5 y5 years | -100.0% | +99.8% | +100.8% |
AKBA Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -100.1% | +71.0% | -181.8% | at low | -80.2% | +121.0% |
| 5 y | 5-year | -100.0% | +99.9% | -100.2% | +99.8% | -100.0% | +100.0% |
| alltime | all time | -100.0% | +100.0% | -100.1% | +99.9% | -100.0% | +100.0% |
AKBA Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$126.00K(-181.8%) | $24.00K(-80.2%) |
| Mar 2025 | - | $154.00K(-7800.0%) | $121.00K(-466.7%) |
| Dec 2024 | -$33.00K(<-9900.0%) | -$2000.00(0.0%) | -$33.00K(+6.5%) |
| Sep 2024 | - | -$2000.00(-93.1%) | -$31.00K(+6.9%) |
| Jun 2024 | - | -$29.00K(<-9900.0%) | -$29.00K(<-9900.0%) |
| Mar 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2023 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2022 | -$114.00K(-100.3%) | $0.00(0.0%) | -$114.00K(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | -$114.00K(0.0%) |
| Jun 2022 | - | $0.00(-100.0%) | -$114.00K(-100.6%) |
| Mar 2022 | - | -$114.00K(<-9900.0%) | $19.89M(-50.2%) |
| Dec 2021 | $39.94M(-199.8%) | $0.00(0.0%) | $39.94M(-59.9%) |
| Sep 2021 | - | $0.00(-100.0%) | $99.62M(+100.5%) |
| Jun 2021 | - | $20.00M(+0.3%) | $49.69M(-344.7%) |
| Mar 2021 | - | $19.94M(-66.6%) | -$20.31M(-49.2%) |
| Dec 2020 | -$40.00M(-118.9%) | $59.68M(-219.5%) | -$40.00M(-48.3%) |
| Sep 2020 | - | -$49.94M(-0.1%) | -$77.41M(+2413.2%) |
| Jun 2020 | - | -$49.99M(<-9900.0%) | -$3.08M(-103.1%) |
| Mar 2020 | - | $245.00K(-98.9%) | $100.95M(-52.2%) |
| Dec 2019 | $211.18M(+477.1%) | $22.28M(-8.7%) | $211.18M(+2.7%) |
| Sep 2019 | - | $24.39M(-54.9%) | $205.61M(+7.0%) |
| Jun 2019 | - | $54.03M(-51.1%) | $192.23M(+42.8%) |
| Mar 2019 | - | $110.47M(+560.8%) | $134.63M(+267.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $36.59M(-120.6%) | $16.72M(+51.8%) | $36.59M(+216.3%) |
| Sep 2018 | - | $11.01M(-408.6%) | $11.57M(-126.1%) |
| Jun 2018 | - | -$3.57M(-128.7%) | -$44.40M(-38.8%) |
| Mar 2018 | - | $12.43M(-249.7%) | -$72.52M(-59.1%) |
| Dec 2017 | -$177.26M(-1495.2%) | -$8.31M(-81.5%) | -$177.26M(+20.9%) |
| Sep 2017 | - | -$44.96M(+41.9%) | -$146.65M(+161.3%) |
| Jun 2017 | - | -$31.69M(-65.7%) | -$56.12M(-1147.6%) |
| Mar 2017 | - | -$92.30M(-513.8%) | $5.36M(-57.8%) |
| Dec 2016 | $12.71M(-192.8%) | $22.31M(-51.0%) | $12.71M(-259.6%) |
| Sep 2016 | - | $45.57M(+53.0%) | -$7.96M(-88.3%) |
| Jun 2016 | - | $29.79M(-135.1%) | -$67.98M(-33.4%) |
| Mar 2016 | - | -$84.95M(-5286.5%) | -$102.05M(+645.5%) |
| Dec 2015 | -$13.69M(-79.1%) | $1.64M(-111.3%) | -$13.69M(-40.4%) |
| Sep 2015 | - | -$14.46M(+238.0%) | -$22.96M(-52.7%) |
| Jun 2015 | - | -$4.28M(-225.6%) | -$48.51M(-27.9%) |
| Mar 2015 | - | $3.40M(-144.6%) | -$67.31M(+3.0%) |
| Dec 2014 | -$65.35M(+472.0%) | -$7.64M(-80.9%) | -$65.35M(+16.7%) |
| Sep 2014 | - | -$40.00M(+73.3%) | -$55.98M(+92.1%) |
| Jun 2014 | - | -$23.07M(-530.7%) | -$29.14M(+380.4%) |
| Mar 2014 | - | $5.36M(+208.8%) | -$6.07M(-46.9%) |
| Dec 2013 | -$11.42M(-936.4%) | $1.74M(-113.2%) | -$11.42M(-13.2%) |
| Sep 2013 | - | -$13.16M(<-9900.0%) | -$13.16M(<-9900.0%) |
| Jun 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $1.37M(-286.6%) | - | - |
| Dec 2011 | -$732.10K | - | - |
FAQ
- What is Akebia Therapeutics, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. annual CFI year-on-year change?
- What is Akebia Therapeutics, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. quarterly CFI year-on-year change?
- What is Akebia Therapeutics, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Akebia Therapeutics, Inc.?
- What is Akebia Therapeutics, Inc. TTM CFI year-on-year change?
What is Akebia Therapeutics, Inc. annual cash flow from investing activities?
The current annual CFI of AKBA is -$33.00K
What is the all time high annual CFI for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high annual cash flow from investing activities is $211.18M
What is Akebia Therapeutics, Inc. annual CFI year-on-year change?
Over the past year, AKBA annual cash flow from investing activities has changed by -$33.00K (-100.00%)
What is Akebia Therapeutics, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of AKBA is -$126.00K
What is the all time high quarterly CFI for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $110.47M
What is Akebia Therapeutics, Inc. quarterly CFI year-on-year change?
Over the past year, AKBA quarterly cash flow from investing activities has changed by -$97.00K (-334.48%)
What is Akebia Therapeutics, Inc. TTM cash flow from investing activities?
The current TTM CFI of AKBA is $24.00K
What is the all time high TTM CFI for Akebia Therapeutics, Inc.?
Akebia Therapeutics, Inc. all-time high TTM cash flow from investing activities is $211.18M
What is Akebia Therapeutics, Inc. TTM CFI year-on-year change?
Over the past year, AKBA TTM cash flow from investing activities has changed by +$53.00K (+182.76%)